Naproxen Esomeprazol Sandoz 500 mg / 20 mg
Naproxen Esomeprazol Sandoz 500 mg / 20 mg is a medicine authorised by Swissmedic under authorisation number 69184. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 November 2024 and the authorisation is limited until 18 November 2029. ATC code M01AE52 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 69184 |
|---|---|
| Name | Naproxen Esomeprazol Sandoz 500 mg / 20 mg |
| Full name | Naproxen Esomeprazol Sandoz 500 mg / 20 mg, Filmtabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M01AE52 |
| First authorisation | 19 November 2024 |
| Authorisation validity | 18 November 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Naproxen Esomeprazol Sandoz 500 mg / 20 mg, Filmtabletten | B | 19 November 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | M01AE52 | 07.10.2. | B |
| 2 | 60 | Tablette(n) | M01AE52 | 07.10.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Naproxen Esomeprazol Sandoz 500 mg / 20 mg authorised in Switzerland?
Yes. Naproxen Esomeprazol Sandoz 500 mg / 20 mg is authorised by Swissmedic under authorisation number 69184, data as of 01 September 2026. The authorisation is limited until 18 November 2029.
Which dispensing category does Naproxen Esomeprazol Sandoz 500 mg / 20 mg have?
Naproxen Esomeprazol Sandoz 500 mg / 20 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Naproxen Esomeprazol Sandoz 500 mg / 20 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.